<DOC>
	<DOCNO>NCT00539214</DOCNO>
	<brief_summary>- To compare effect pramipexole depressive symptom early advance PD patient - To evaluate course depressive symptom measure UPDRS Part I ( mentation , behavior mood ) HADS-D pramipexole treatment - To investigate whether improvement depressive symptom link improvement motor function ( UPDRS Part III )</brief_summary>
	<brief_title>Non-interventional Observational Study With Pramipexole : Impact Non-motor Symptoms Parkinson 's Disease</brief_title>
	<detailed_description>Study Design :</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Inclusion criterion : 1 . Idiopathic Parkinsons disease without fluctuation 2 . Indication treatment Sifrol® 3 . Male female patient age 4 . Presence least mild depressive symptom ( judged treat physician ) 5 . Ability reliably complete selfrating scale ( HADS ) Exclusion criterion : 1 . Any contraindication accord Summary Product Characteristics ( SPC ) : hypersensitivity pramipexole excipients . 2 . Ongoing treatment Sifrol® .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>